These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6739223)

  • 1. Tritiation of vasopressin analogues and their metabolic fate after intravenous injection in the rat.
    Janáky T; László FA; Morgat JL
    Acta Med Hung; 1984; 41(1):43-54. PubMed ID: 6739223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological half-lives and organ distribution of tritiated 8-lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin in Brattleboro rats.
    Janáky T; Laczi F; László FA
    Ann N Y Acad Sci; 1982; 394():116-27. PubMed ID: 6960751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological half-life and organ distribution of [3H]1-deamino-8-D-arginine-vasopressin in the rat.
    László FA; Janáky T; Baláspiri L; Morgat JL
    J Endocrinol; 1981 Feb; 88(2):181-6. PubMed ID: 7205124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological half-life and organ distribution of [3H]8-arginine vasopressin following administration of vasopressin receptor antagonist OPC-31260.
    Molnár AH; Varga C; Janáky T; Tóth G; Tóth G; Farkas J; László F; László FA
    Regul Pept; 2007 Jun; 141(1-3):12-8. PubMed ID: 17258819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological half-life and organ distribution of [3H]8-arginine-vasopressin in the rat.
    Janáky T; László FA; Sirokmán F; Morgat JL
    J Endocrinol; 1982 Jun; 93(3):295-303. PubMed ID: 7086324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the biological half-life and organ-distribution of tritiated lysine-vasopressin in Brattleboro rats.
    Laczi F; László FA; Kéri G; Teplán I
    Acta Physiol Acad Sci Hung; 1980; 55(2):129-33. PubMed ID: 7435206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thirsting on biological half-life and organ distribution of 3H-dDAVP in rat.
    Janáky T; László FA; Baláspiri L; Morgat JL
    Horm Metab Res; 1982 Jul; 14(7):385-6. PubMed ID: 7118063
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoradiographic localization of 3H-dDAVP in the rat kidney.
    László FA; Morgat JL; Halász N; Joó F
    Horm Metab Res; 1981 Aug; 13(8):474-5. PubMed ID: 7327529
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of lysine-vasopressin (LVP) and 1-deamino-8-D-arginine-vasopressin (dDAVP) upon electrical potential, short-circuit current and transepithelial D.C. resistance of the frog skin.
    Bakos P; Ponec J; Lichardus B
    Gen Physiol Biophys; 1984 Aug; 3(4):297-305. PubMed ID: 6094299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the blood-brain barrier to peptides: accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions.
    Ermisch A; Barth T; Rühle HJ; Skopková J; Hrbas P; Landgraf R
    Endocrinol Exp; 1985 Mar; 19(1):29-37. PubMed ID: 3872788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-cerebrospinal fluid barrier to arginine-vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog.
    Ang VT; Jenkins JS
    J Endocrinol; 1982 Jun; 93(3):319-25. PubMed ID: 7086325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of [mercaptopropionic acid1, D-arginine8]-vasopressin (dDAVP) in pancreatic juice and intestinal mucosa homogenate.
    Lundin S; Bengtsson HI; Folkesson HG; Weström BR
    Pharmacol Toxicol; 1989 Aug; 65(2):92-5. PubMed ID: 2813288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDAVP (1-desamino-8-D-arginine vasopressin) clearance rate.
    Stegner H; Artman HG; Leake RD; Fisher DA
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):204-6. PubMed ID: 6495988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thirsting on the biological half-life and organ-distribution of 3H-lysin vasopressin.
    László FA; Nagy E; Gáspár L; Kéri G; Teplán I
    Horm Metab Res; 1980 Sep; 12(9):471-5. PubMed ID: 7429417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP).
    Yamaguchi Y; Yamada K; Suzuki T; Wu YP; Kita K; Takahashi S; Ichinose M; Suzuki N
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E970-6. PubMed ID: 15198931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of 1-desamino-8-D-arginine vasopressin (DDAVP) in patients with central diabetes insipidus.
    Pullan PT; Burger HG; Johnston CI
    Clin Endocrinol (Oxf); 1978 Sep; 9(3):273-8. PubMed ID: 709897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma half-lives of vasopressin and oxytocin analogs after iv injection in rats.
    Gazis D
    Proc Soc Exp Biol Med; 1978 Sep; 158(4):663-5. PubMed ID: 693485
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of vasopressin, oxytocin and their analogues [Mpa1, D-Arg8]-vasopressin (dDAVP) and [Mpa1, D-Tyr(Et)2, Thr4, Orn8]-oxytocin (antocin) in human kidney and liver homogenates.
    Fjellestad-Paulsen A; Lundin S
    Regul Pept; 1996 Nov; 67(1):27-32. PubMed ID: 8952002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications for a brain uptake of labelled vasopressin and ocytocin and the problem of the blood-brain barrier.
    Landgraf R; Ermisch A; Hess J
    Endokrinologie; 1979 Feb; 73(1):77-81. PubMed ID: 467364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tritiation of [8-L-arginine, 9-desglycineamide] vasopressin.
    Hrbas P; Cerný B; Papsuevich OS; Chipens GI; Ermisch A; Barth T
    Endocrinol Exp; 1989 Mar; 23(1):37-42. PubMed ID: 2714226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.